Gemigliptin tartrate sesquihydrate and metformin

DRUG2 trials

Sponsors

LG Chem

Conditions

Type 2 DiabetesType2 Diabetes

Phase 1

Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.

LG ChemType2 Diabetes

Start: 2019-11-01End: 2019-11-30Target: 24Updated: 2019-08-08

Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.

CompletedNCT04317703

LG ChemType 2 Diabetes

Start: 2020-08-19End: 2020-09-05Updated: 2021-02-09